Maternal antimullerian hormone as a predictor of fetal aneuploidy occurring in an early pregnancy loss.
Maternal antimullerian hormone as a predictor of fetal aneuploidy occurring in an early pregnancy loss.
复制标题
DOI：
10.5468/ogs.2015.58.6.494
复制
发表时间：
2015-11-01
影响因子：
--
通讯作者：
Park, Hee Jin
中科院分区：
文献类型：
--
作者：
Shim, So Hyun;Ha, Hyeong In;Park, Hee Jin
OBJECTIVE: The purpose of the study was to examine the relationship between the parameter representing ovarian reserve and the fetal aneuploidy in early spontaneous miscarriage.METHODS: A multicenter retrospective cohort study was performed in patients who were diagnosed with early pregnancy loss (≤13 gestational weeks) and examined for fetal karyotype at the CHA Gangnam Medical Center, CHA Bundang Medical Center, and CHA Gumi Medical Center between January 2011 and December 2012. Karyotyping was performed by the Genetic Laboratory of the Fertility Center of CHA Gangnam Medical Center. Medical records were reviewed for demographics, karyotype analysis and hormonal assay of ovarian reserve including antimullerian hormone (AMH) and follicle stimulating hormone. Statistical analysis was performed using SPSS software.RESULTS: A total 462 patients were included in this study. The mean age of the patients was 35.31±4.12 years and the mean AMH level was 3.88±3.50 ng/mL (n=195). Two hundred eleven conceptuses (45.7%) of patients showed the euploid and 251 (54.3%) showed the aneuploid. There are significant differences in maternal age, AMH and gestational age between fetal euploid and aneuploid groups (34.46±4.35 vs. 36.04±3.78 years, P
